The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Low Serum Thyrotropin Level and Duration of Suppression as a Predictor of Major Osteoporotic Fractures—The OPENTHYRO Register Cohort
Abstract
The relationship between thyrotoxicosis and osteoporotic fractures remains controversial, particularly in men. Register-based cohort study including all patients with a serum thyrotropin (TSH) measurement in the region of Funen 1996–2010. All TSH determinations were done in the same lab, which served all hospitals and General Practice (GP) practices in the region. Persons with raised TSH or a history of thyroid/pituitary disease or use of thyroid medications were excluded. The study population consisted of 222,138 (96%) persons with normal and 9217 (4%) with low TSH (<0.3 mIU/L). A single low TSH at baseline was associated with increased risk of hip fractures (adj HR 1.16, 95% CI 1.07–1.26, p < 0.001) but not major osteoporotic fractures (MOF, adj HR 1.06, 95% CI 0.99–1.12, p = 0.058) over a median follow-up of 7.5 years. When men were analyzed separately, results did not reach statistical significance. We found a significant association between duration of thyrotoxicosis and fracture. For each 6 months in which the mean TSH value was decreased (<0.3 mIU/L), hip fracture risk increased by a factor 1.07 (adj HR, 95% CI 1.04–1.10, p < 0.001) and MOF by 1.05 (adj HR, 95% CI 1.03–1.07, p < 0.001). Overt thyrotoxicosis was associated with an increased risk of hip fractures but not MOF. In euthyroid patients, the risk of fractures increased significantly with each SD unit of TSH decrease: Hip fracture (HR 1.45, 95% CI 1.22–1.71, p < 0.001) and MOF (HR 1.32, 95% CI 1.19–1.46, p < 0.001). In a population-based cohort, a single, first measurement of decreased TSH in patients without known thyroid disease was associated with an increased long-term risk of hip fracture, which remained significant in women but not in men after adjusting for confounders. Moreover, the risk of both hip fracture and MOF increased exponentially by the length of time during which TSH had remained low. © 2014 American Society for Bone and Mineral Research
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This large-scale study demonstrated a clear correlation between level of TSH, duration of low TSH and risk of osteoporotic fractures in relation to age and sex [30] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [30]
In the citing paper
“In a population-based cohort study, a single first measurement of decreased TSH was associated with an increased long-term risk of hip fractures in older women [30] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [30]
In the citing paper
“Differences in the degree of TSH suppression, causes of SHyper, patient age and duration of TSH suppression may influence the adverse consequences of Endo SHyper [3,5,30] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [30]
In the citing paper
“In fact, the effects of SHyper are likely influenced by the duration of the disease and associated risk factors for bone loss [30] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [30]
In the citing paper
“Variation in thyrotropin (TSH) levels within the normal reference range generally shows an inverse relationship with fracture risk so that low-normal TSH values are associated with modest increases in the risk of fractures.(13)(14)(15) and with decreases in BMD.(13,16)”
In the citing paper
“The impact of low TSH in this setting was very similar to that previously found by our group in patients with spontaneous hyperthyroidism using the same methodology (14)”
In the citing paper
“Risk increased with duration of SH, such that after a median follow-up of 7.5 years, 13.5% of subjects with a low TSH level had experienced at least one major osteoporotic fracture, compared to 6.9% of subjects with a normal TSH level (407).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [407]
In the citing paper
“The most recent and by far the largest individual study to date (231,355 subjects) reported a hazard rate for all major osteoporotic fractures combined (hip, humerus, forearm, spine) of 1.13 [confidence intervals 1.014-1.26].”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [407]
In the citing paper
“A number of population-based studies have reported that certain groups of subjects with SH have increased fracture rates, including all adults (407), postmenopausal women (408), men (409), or subjects who progress to overt hyperthyroidism over time (391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [407]
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Excess mortality following hip fracture: a systematic epidemiological review
Abrahamsen, B., van Staa, T., Ariely, R., Olson, M., & Cooper, C. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0920-3 · Cited by 1,079
Self-citationOsteoporosis in the European Union: a compendium of country-specific reports
IOF, T. E. R. P. O. T., Svedbom, A., Hernlund, E., Ivergård, M., Compston, J., Cooper, C. C., Stenmark, J., McCloskey, E. V., Jönsson, B., & Kanis, J. A. (2013) · Archives of Osteoporosis · doi:10.1007/s11657-013-0137-0 · Cited by 740
The Danish prescription registries.
Gaist, D., Sørensen, H. T., & Hallas, J. (1997) · PubMed · Cited by 570
Kannegaard, P. N., Mark, S., Eiken, P., & Abrahamsen, B. (2010) · Age and Ageing · doi:10.1093/ageing/afp221 · Cited by 534
Self-citationRisk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467
Effects of thyroid hormones on bone and mineral metabolism
Mosekilde, L., Eriksen, E. F., & Charles, P. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30338-4 · Cited by 423
Flynn, R. W., Bonellie, S. R., Jung, R. T., MacDonald, T. M., Morris, A. D., & Leese, G. P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1625 · Cited by 415
Research works printed but not linked: 1
- McCloskey, 2009, From relative risk to absolute fracture risk calculation: the FRAX algorithm, CurrOsteoporosRep., 7, 77
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“A number of population-based studies have reported that certain groups of subjects with SH have increased fracture rates, including all adults (407), postmenopausal women (408), men (409), or subjects who progress to overt hyperthyroidism over time (391).”
BackgroundGharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedűs, L. D., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,285
Self-citationRole of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & CANALIS, E. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 343
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationThyroid diseases and bone health
Williams, G. R., & Bassett, J. H. D. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0753-4 · Cited by 276
Lillevang-Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedüs, L. (2018) · Thyroid · doi:10.1089/thy.2017.0517 · Cited by 150
Self-citationLillevang‐Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedűs, L. D. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00166 · Cited by 114
Self-citationLillevang-Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedüs, L. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0006 · Cited by 100
Self-citationReference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
Jonklaas, J., & Razvi, S. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30371-1 · Cited by 100
Lillevang‐Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedűs, L. D. (2019) · Thyroid · doi:10.1089/thy.2018.0320 · Cited by 103
Self-citationAbrahamsen, B., Jørgensen, H. L., Laulund, A. S., Nybo, M., Bauer, D. C., Brix, T. H., & Hegedüs, L. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2416 · Cited by 98
Self-citationCramon, P. K., Winther, K. H., Watt, T., Bonnema, S. J., Bjørner, J. B., Ekholm, O., Grøenvold, M., Hegedűs, L. D., Feldt‐Rasmussen, U., & Rasmussen, Å. K. (2016) · Thyroid · doi:10.1089/thy.2016.0044 · Cited by 77
Self-citationVegan Diet and Bone Health—Results from the Cross-Sectional RBVD Study
Menzel, J., Abraham, K., Stangl, G. I., Ueland, P. M., Obeid, R., Schulze, M. B., Herter‐Aeberli, I., Schwerdtle, T., & Weikert, C. (2021) · Nutrients · doi:10.3390/nu13020685 · Cited by 72
Tsourdi, E. A., Rijntjes, E., Köhrle, J., Hofbauer, L. C., & Rauner, M. (2015) · Endocrinology · doi:10.1210/en.2015-1073 · Cited by 64
DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disorders
Eller-Vainicher, C., Falchetti, A., Gennari, L., Cairoli, E., Bertoldo, F., Vescini, F., Scillitani, A., & Chiodini, I. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0991 · Cited by 66
Folkestad, L., Brandt, F., Lillevang‐Johansen, M., Brix, T. H., & Hegedűs, L. D. (2020) · Thyroid · doi:10.1089/thy.2019.0672 · Cited by 63
Self-citationMazziotti, G., Formenti, A. M., Frara, S., Olivetti, R., Banfi, G., Memo, M., Maroldi, R., Giubbini, R., & Giustina, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01986 · Cited by 57
Actions of pituitary hormones beyond traditional targets
Zaidi, M., New, M. I., Blair, H. C., Zallone, A. Z., Baliram, R., Davies, T. F., Cardozo, C. P., Iqbal, J., Sun, L., Rosen, C. J., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0680 · Cited by 63
Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study
Papaleontiou, M., Chen, D., Banerjee, M., Reyes‐Gastelum, D., Hamilton, A. S., Ward, K. C., & Haymart, M. R. (2021) · Thyroid · doi:10.1089/thy.2021.0033 · Cited by 49
Thyroid disease: Long-term management of hyperthyroidism and hypothyroidism
Hughes, K., & Eastman, C. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-09-20-5653 · Cited by 48
Moon, J. H., Kim, K. M., Oh, T. J., Choi, S. H., Lim, S. K., Park, Y. J., Park, D. J., & Jang, H. C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2740 · Cited by 46
Thyroid disease in the perimenopause and postmenopause period
Uygur, M. M., Yoldemir, T., & Yavuz, D. G. (2018) · Climacteric · doi:10.1080/13697137.2018.1514004 · Cited by 45
Yan, Z., Huang, H., Li, J., & Wang, J. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3221-z · Cited by 43
Rubin, K. H., Glintborg, D., Nybo, M., Andersen, M., & Abrahamsen, B. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2737 · Cited by 43
Self-citationIndividualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Drugs in Context · doi:10.7573/dic.212597 · Cited by 41
Thyrotropin, Hyperthyroidism, and Bone Mass
Kim, S., Ryu, V., Miyashita, S., Korkmaz, F., Lizneva, D., Gera, S., Latif, R., Davies, T. F., Iqbal, J. Z., Yuen, T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab548 · Cited by 42
Pituitary crosstalk with bone, adipose tissue and brain
Zaidi, M., Yuen, T., & Kim, S. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00894-5 · Cited by 44
Siru, R., Alfonso, H. S., Chubb, S. A. P., Golledge, J., Flicker, L. A., & Yeap, B. B. (2018) · Clinical Endocrinology · doi:10.1111/cen.13615 · Cited by 40
The management and metabolic characterization: hyperthyroidism and hypothyroidism
Wang, Y., Sun, Y., Yang, B., Wang, Q., & Kuang, H. (2022) · Neuropeptides · doi:10.1016/j.npep.2022.102308 · Cited by 34
Moon, J. H., Jung, K. Y., Kim, K. M., Choi, S. H., Lim, S. K., Park, Y. J., Park, D. J., & Jang, H. C. (2015) · Bone · doi:10.1016/j.bone.2015.10.015 · Cited by 33
Zhu, H., Zhang, J., Wang, J., Zhao, X., & Gu, M. (2020) · Endocrine · doi:10.1007/s12020-019-02110-9 · Cited by 28
Update on the treatment of hypothyroidism
Jonklaas, J. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000242 · Cited by 25
Nicolaisen, P., Obling, M. L., Winther, K. H., Hansen, S., Hermann, A. P., Hegedűs, L. D., Bonnema, S. J., & Brix, T. H. (2020) · Thyroid · doi:10.1089/thy.2020.0084 · Cited by 24
Self-citationLee, K., Lim, S., Park, H. H., Woo, H., Chang, Y., Sung, E., Jung, H. S., Yun, K. E., Kim, C., Ryu, S., et al. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05205-1 · Cited by 27
How does Hashimoto’s thyroiditis affect bone metabolism?
Wu, J., Huang, H., & Yu, X. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09778-x · Cited by 25
Levothyroxine Poisoning – Symptoms and Clinical Outcome
Nygaard, B., Sædder, E. A., Dalhoff, K., Wikkelsoe, M., & Jűrgens, G. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12401 · Cited by 24
Effect of subclinical hyperthyroidism on osteoporosis: A meta-analysis of cohort studies
Xu, N., Wang, Y., Xu, Y., Li, L., Chen, J., Mai, X., Xu, J., Zhang, Z., Yang, R., Sun, J. M., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02259-8 · Cited by 23
Low Normal TSH levels are Associated with Impaired BMD and Hip Geometry in the Elderly
Lee, S. J., Kim, K. M., Lee, E. Y., Song, M. K., Kang, D. R., Kim, H. C., Youm, Y., Yun, Y. M., Park, H., Kim, C. O., et al. (2016) · Aging and Disease · doi:10.14336/ad.2016.0325 · Cited by 22
Pituitary-bone connection in skeletal regulation
Zaidi, M., Sun, L., Liu, P., Davies, T. F., New, M. I., Zallone, A. Z., & Yuen, T. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0015 · Cited by 21
Association between Sensitivity to Thyroid Hormone Indices and Bone Mineral Density in US Males
Chen, S., Huang, W., Zhou, G., Sun, X., Jin, J., & Li, Z. (2022) · International Journal of Endocrinology · doi:10.1155/2022/2205616 · Cited by 21
Skeletal health in patients with differentiated thyroid carcinoma
Cellini, M., Rotondi, M., Tanda, M. L., Piantanida, E., Chiovato, L., Beck‐Peccoz, P., Lania, A. G., & Mazziotti, G. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01359-6 · Cited by 20
Lambrinoudaki, I. V., Armeni, E., Pliatsika, P., Rizos, D., Kaparos, G., Augoulea, A., Alexandrou, A. P., Flokatoula, M., Creatsa, M. G., Panoulis, C., et al. (2016) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-016-0752-0 · Cited by 19
Lakatos, P. A., Bakos, B., Takács, I., & Stern, P. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00038-5 · Cited by 19
Vendrami, C., Marques-Vidal, P. M., Rodríguez, E. G., Hans, D. B., Waeber, G., & Lamy, O. (2021) · Osteoporosis International · doi:10.1007/s00198-021-06081-4 · Cited by 18
Evaluation and management of skeletal disease in cancer care
Kommalapati, A., Tella, S. H., Esquivel, M. A., & Correa, R. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.09.003 · Cited by 17
Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men
Svensson, J., Ohlsson, C., Karlsson, M. K., Lorentzon, M., Lewerin, C., & Mellström, D. (2021) · Osteoporosis International · doi:10.1007/s00198-021-05964-w · Cited by 18
Fang, H., Zhao, R., Cui, S., & Wan, W. (2022) · Aging · doi:10.18632/aging.204352 · Cited by 15
Long-term antithyroid drug therapy
Cooper, D. S. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000656 · Cited by 16
Büchi, A. E., Feller, M., Netzer, S., Blum, M. R., Gonzalez Rodriguez, E., Collet, T.-H., Del Giovane, C., van Heemst, D., Quinn, T., Kearney, P. M., et al. (2022) · Bone · doi:10.1016/j.bone.2022.116404 · Cited by 14
Williams, G. R. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0110-9 · Cited by 14
Regulation of bone mass in endocrine diseases including diabetes
Higham, C., & Abrahamsen, B. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101614 · Cited by 13
Self-citationTsourdi, E. A., Wallaschofski, H., Rauner, M., Nauck, M. A., Pietzner, M., Rettig, R., Ittermann, T., Völzke, H., Völker, U., Hofbauer, L. C., et al. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3276-x · Cited by 13
Independent Skeletal Actions of Pituitary Hormones
Kim, S. M., Sultana, F., Korkmaz, F., Lizneva, D., Yuen, T., & Zaidi, M. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1573 · Cited by 12
Approach to the Patient With a Suppressed TSH
Praw, S. S., & Brent, G. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac635 · Cited by 13
Kim, S., Sultana, F., Korkmaz, F., Rojekar, S. V., Pallapati, A., Ryu, V., Lizneva, D., Yuen, T., Rosen, C. J., & Zaidi, M. (2024) · Pituitary · doi:10.1007/s11102-024-01437-5 · Cited by 11
Fracture Incidence in Graves' Disease: A Population-Based Study
Khamisi, S., Udumyan, R., Sjölin, G., Calissendorff, J., Nyström, H. F., Holmberg, M., Hallengren, B., Lantz, M., Planck, T., Wallin, G., et al. (2023) · Thyroid · doi:10.1089/thy.2023.0162 · Cited by 11
Auswirkungen von Schilddrüsenfunktionsstörungen auf den Knochen
Tsourdi, E. A., Lademann, F., & Siggelkow, H. (2018) · Der Internist · doi:10.1007/s00108-018-0436-z · Cited by 11
Chandrupatla, S. R., Rumalla, K. C., & Singh, J. A. (2023) · The Journal of Arthroplasty · doi:10.1016/j.arth.2023.11.005 · Cited by 10
Papini, E., Attanasio, R., Žarković, M., Nagy, E. V., Negro, R., Perros, P., Galofré, J. C., Cohen, C. A., Akarsu, E., Alevizaki, M. K., et al. (2024) · Endocrine · doi:10.1007/s12020-024-04002-z · Cited by 9
Self-citationHoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100219 · Cited by 10
Thyroid Hormones, Glucocorticoids, Insulin, and Bone
Lakatos, P. L., Szili, B., Bakos, B., Takács, I., Putz, Z., & Istenes, I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_314 · Cited by 9
Ali, M. S., Ernst, M., Robinson, D. E., Caskey, F. J., Arden, N., Ben‐Shlomo, Y., Nybo, M., Rubin, K. H., Judge, A., Cooper, C. C., et al. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00746-z · Cited by 9
Self-citationThe relationship of hip fracture and thyroid disorders: a systematic review
SeyedAlinaghi, S., Yarmohammadi, S., Dashti, M., Ghasemzadeh, A., Siami, H., Molla, A., Mahrokhi, S., Qaderi, K., Arjmand, G., Parikhani, S. N., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1230932 · Cited by 9
Lademann, F., Tsourdi, E. A., Hofbauer, L. C., & Rauner, M. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30500 · Cited by 8
Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts
Lademann, F., Rijntjes, E., Köhrle, J., Tsourdi, E., Hofbauer, L. C., & Rauner, M. (2024) · Communications Biology · doi:10.1038/s42003-024-06227-0 · Cited by 8
Obling, M. L., Nicolaisen, P., Brix, T. H., Winther, K. H., Hansen, S., Hegedűs, L. D., Hermann, A. P., & Bonnema, S. J. (2020) · Endocrine · doi:10.1007/s12020-020-02398-y · Cited by 7
Self-citationRobinson, D. E., Ali, M. S., Strauss, V. Y., Elhussein, L., Abrahamsen, B., Arden, N., Ben‐Shlomo, Y., Caskey, F. J., Cooper, C. C., Dedman, D., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25170 · Cited by 8
Self-citationThyroid-stimulating hormone (TSH) is associated with 30-day mortality in hip fracture patients
Rapacki, E., Lauritzen, J. B., Madsen, C. M., Jørgensen, H. L., & Norring-Agerskov, D. (2019) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-019-01260-9 · Cited by 7
Self-citationAytekin, Z., & Yılmaz, S. G. (2021) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2021.10.011 · Cited by 6
Are Dietary Habits the Missing Link Between Hashimoto’s Thyroiditis and Osteoporosis?
Vergatti, A., Abate, V., Garofano, F., Fiore, A., FILIPPO, G. D., Strazzullo, P., & Rendina, D. (2025) · Nutrients · doi:10.3390/nu17132109 · Cited by 7
Chopra, R., Kalaria, T., Gherman‐Ciolac, C., Raghavan, R., Buch, H., & Kar, N. (2023) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_474_22 · Cited by 7
Laine, C. M., & Landin‐Wilhelmsen, K. (2017) · Osteoporosis International · doi:10.1007/s00198-017-3981-8 · Cited by 6
Thyroid and bone turnover markers in type 2 diabetes: results from the METAL study
Chen, Y., Zhang, W., Chen, C., Wang, Y., Wang, N., & Lu, Y. (2022) · Endocrine Connections · doi:10.1530/ec-21-0484 · Cited by 7
Enhanced Well-Being Associated with Thyrotoxicosis: A Neglected Effect of Thyroid Hormones?
Perros, P., & Hegedűs, L. D. (2022) · Intern J Endocrinol Metab · doi:10.5812/ijem-127230 · Cited by 5
Self-citationHigher serum free thyroxine levels are associated with increased risk of hip fractures in older men
Svensson, J., Ohlsson, C., Karlsson, M. K., Herlitz, H., Lorentzon, M., Lewerin, C., & Mellström, D. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjad005 · Cited by 6
Toxic Adenoma and Multinodular Toxic Goiter
Tonacchera, M., & Führer, D. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_18 · Cited by 5
Skeletal Effects of Thyroid Hormones
Bakos, B., Takács, I., Stern, P. H., & Lakatos, P. L. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9246-z · Cited by 4
Knowledge gaps about the diagnosis and treatment of hypothyroidism: an international patient survey
Perros, P., Poots, A. J., Nagy, E. V., Papini, E., Hay, H. A., Abad-Madroñero, J., Tallett, A. J., Lakwijk, P., & Hegedűs, L. D. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1663497 · Cited by 3
Self-citationEszlinger, M., Hegedűs, L. D., & Paschke, R. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_6 · Cited by 3
Self-citationVinther, C. J., Poulsen, L., Nicolaisen, P., Obling, M. L., Brix, T. H., Hermann, A. P., Hegedűs, L. D., Jørgensen, N. R., Hansen, S., & Bonnema, S. J. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01907-2 · Cited by 3
Self-citationImpact of subclinical hyperthyroidism on bone
Koutroumpi, S., Stratigou, T., & Vlassopoulou, V. (2019) · Journal of Research and Practice on the Musculoskeletal System · doi:10.22540/jrpms-03-060 · Cited by 2
Ghosh, R., Auh, S., Gubbi, S., Veeraraghavan, P., Cochran, C. S., Shobab, L. A., Urken, M. L., Burman, K. D., Wartofsky, L., & Kłubo-Gwieździńska, J. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae537 · Cited by 2
Pituitary Hormone-Driven Mechanism for Skeletal Loss
Yuen, T., Sun, L., Abu‐Amer, W., Liu, P., Davies, T. F., Blair, H. C., New, M. I., Zallone, A. Z., & Zaidi, M. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-56192-9_10 · Cited by 2
Thyroid Hormone in Bone and Joint Disorders
Bassett, J. H. D., & Williams, G. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00031-9 · Cited by 2
Endocrinology of Bone and Growth Disorders
Farquharson, C., Stephen, L. A., & Wong, S. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00086-4 · Cited by 3
Bonnema, S. J., & Hegedűs, L. D. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_5 · Cited by 2
Self-citationToxic Adenoma and Multinodular Toxic Goiter
Tonacchera, M., & Führer, D. (2017) · Endocrinology · doi:10.1007/978-3-319-29195-6_18-1 · Cited by 1
Subclinical thyrotoxicosis and bone
Doga, M., Formenti, A. M., Frara, S., Memo, M., Giustina, A., & Mazziotti, G. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.03.002 · Cited by 1
Thyroid disease in peri‑ and postmenopause period (literature review)
Zaidieva, Y. Z., Glazkova, A. V., & Kruchinina, E. V. (2020) · Medical alphabet · doi:10.33667/2078-5631-2019-4-33(408)-48-53 · Cited by 1
Nygaard, B. (2022) · doi:10.1093/med/9780198870197.003.0072 · Cited by 1
Menopausal osteoporosis in the practice of a gynecologist
Kuznetsova, I. V., & Chilova, R. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-320-331 · Cited by 1
Thyroid Disorders in Climacteric Women
Brona, A., Milewicz, A., Kuliczkowska-Płaksej, J., & Bolanowski, M. (2018) · ISGE series · doi:10.1007/978-3-319-63540-8_8
Langdahl, B. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65361-8
The Pituitary–Bone Axis in Health and Disease
Zaidi, M., Yuen, T., Abu-Amer, W., Liu, P., Davies, T., New, M., Blair, H., Zallone, A., Rosen, C., & Sun, L. (2018) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9781119266594.ch133
The Role of TSH Suppression in the Management of Differentiated Thyroid Cancer
Alrezk, R., & Kłubo-Gwieździńska, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_47
Janssen, O. E., & Bullmann, C. (2019) · Der Nuklearmediziner · doi:10.1055/a-0916-6728
Thyroid hormone, thyroid medication, and the skeleton
Freudenthal, B., Watts, L., Bassett, J. H. D., & Williams, G. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00046-0
Webb, J. H. J. (2014) · Cross Connect (Southern Cross University)
Metadata
- Authors
- Abrahamsen, B., Jørgensen, H. L., Laulund, A. S., Nybo, M., Brix, T. H., & Hegedüs, L.
- Affiliations
- University of Southern Denmark (DK)
- Bispebjerg Hospital (DK)
- Odense University Hospital (DK)
- Department of Endocrinology and MetabolismOdense University HospitalOdenseDenmark
- Corresponding author
- Abrahamsen, Bo
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-09
- Volume
- 29
- Issue
- 9
- Pages
- 2040-2050
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1712440049
- Cited by
- 112
- References
- 41
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 7 · 2023: 6 · 2022: 14 · 2021: 11 · 2020: 10 · 2019: 14 · 2018: 13 · 2017: 10 · 2016: 8 · 2015: 10 · 2014: 3
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Amgen
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- TSH suppression, thyrotoxicosis, osteoporotic fractures, hip fracture, major osteoporotic fracture, overt hypothyroidism, fracture risk prediction, Funen, thyroid function tests, euthyroid patients, pituitary disorders, thyroid medication
- MeSH terms
- Adolescent, Adult, Aged, Denmark, Dose-Response Relationship, Drug, Female, Hospitals, Humans, Male, Middle Aged, Reference Values, Registries, Thyrotoxicosis, Thyrotropin, Cohort Studies, Incidence, Proportional Hazards Models, Survival Analysis, Young Adult, General Practice, Osteoporotic Fractures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
